C
Compass Therapeutics Inc.
NASDAQ:CMPX
Compass Therapeutics Inc.
NASDAQ:CMPX
Price:
5.2
USD
-2.44%
Market Cap:
$936.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Compass Therapeutics Inc.
NASDAQ:CMPX
|
US |
|
Addus Homecare Corp
NASDAQ:ADUS
|
US |
|
D
|
Demco PCL
SET:DEMCO
|
TH |
|
M
|
Marel hf
ICEX:MAREL
|
IS |
|
Conifex Timber Inc
TSX:CFF
|
CA |
|
Q
|
Quality Construction Products PCL
SET:Q-CON
|
TH |
|
O
|
Orion Office Reit Inc
NYSE:ONL
|
US |
|
Verditek PLC
LSE:VDTK
|
UK |
|
Shanta Gold Ltd
LSE:SHG
|
GG |
|
Zhejiang Sunriver Culture Co Ltd
SSE:600576
|
CN |
Multiples-Based Value
The Multiples-Based Value of one CMPX stock under the Base Case scenario is hidden USD. Compared to the current market price of 5.2 USD, Compass Therapeutics Inc. is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CMPX Multiples-Based Value
LOCKED
Multiples Across Competitors
CMPX Competitors Multiples
Compass Therapeutics Inc. Competitors
Compass Therapeutics Inc. Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
C
|
Compass Therapeutics Inc.
NASDAQ:CMPX
|
950.5m USD | 0 | -14.5 | -10.7 | -10.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
373.2B USD | 6.1 | 89.2 | 14.8 | 20.5 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD | 109.4 | -1 708.3 | 15 870 | -1 791.9 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.9B USD | 5.7 | 19.8 | 12.4 | 15.3 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.2B USD | 9.3 | 28.1 | 21.1 | 22 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80B USD | 5.5 | 17.4 | 12.9 | 14.7 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69.6B AUD | 3.2 | 34.9 | 11.5 | 14.4 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
